Additional indications vary between drugs, with semaglutide approved for use in 12 years and above for weight management, while tirzepatide is approved for use in 10-year-olds and above for T2DM Both medications share similar gastrointestinal side effects, which leads many patients to discontinue use, as well as boxed warnings regarding the risk of thyroid tumors
Recent improvements in attainment of the hemoglobin A1c target of 7
Ozempic is the brand name for semaglutide, a prescription injection approved by the FDA to treat Type 2 diabetes
The symptoms of B12 deficiency are easy to dismiss
Because no approved product licence or SmPC currently exists for retatrutide in the UK, the device-specific instructions below reflect general best practice for subcutaneous self-injection
The WeightCare tirzepatide monthly program costs $499 per month, with doses ranging from 2.5mg to 15mg per week